AXA Shares Dip at Close Following Mixed Recommendation from Deutsche Bank
AXA shares closed the session on Friday, January 9, 2026, at 39.99 euros, down by 1.11% compared to the previous day. This decline is part of a fragile weekly dynamic, with a decrease of 2.37% over seven days, although the stock still maintains a positive annual growth of 14.75%. Trading volume remained moderate, with only 0.21% of the capital traded during the day. This movement comes a few days after the publication of a buy recommendation from Deutsche Bank on January 7, which set a price target at 45 euros, representing a potential increase of 12.5% from the current level. Technically, the stock is now trading below its 200-day moving average, set at 40.39 euros, indicating some medium-term vulnerability. The RSI stands at 48, in a neutral position, with no signs of overbuying or overselling. This configuration suggests a market without excess, but the stock remains under pressure as long as it does not manage to reclaim the symbolic threshold of 40 euros.
Recent analyst recommendations present a mixed picture. While Deutsche Bank has just initiated coverage with a target of 45 euros, KBW raised its target to 47 euros in December, with an outperformance recommendation. Conversely, AlphaValue lowered its target from 50 to 44.90 euros at the end of November, citing a slowdown in the corporate insurance segment, while maintaining an accumulation recommendation. These divergences reflect uncertainties surrounding the group's ability to meet its growth targets for operating income per share, which is expected to be between 6% and 8% per year for the period 2023-2026. The next major event for investors will be the publication of the 2025 annual results, scheduled for February 26. Until then, the stock will need to defend its technical support threshold at 38.19 euros, while resistance is at 41.20 euros. The solvency ratio of 222% published at the end of October and the control of claims related to natural disasters are reassuring factors for shareholders, in a context where the European insurance sector remains under scrutiny.
